BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 1262: GIVE KIDS A CHANCE ACT OF 2025; PROVISIONS RELATED TO RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM REAUTHORIZATION S 932: GIVE KIDS A CHANCE ACT OF 2025; PROVISIONS RELATED TO RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM REAUTHORIZATION GENERAL DISCUSSIONS REGARDING ORPHAN DRUG ACT, HEALTH AND HUMAN SERVICES (HHS) RESTRUCTURING, MANUFACTURER-SPONSORED GENETIC SCREENING, PRIORITY REVIEW VOUCHER (PRV) EXTENSION, MEDICAID, NEWBORN SCREENING
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN EDWARD GREISSING | — |
| KATHRYN LOWELL | — |
Medicare/Medicaid MMM
HR 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS OF THE BILL S 752: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING MEDICAID REFORM
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN EDWARD GREISSING | — |
Tariff (miscellaneous tariff bills) TAR
GENERAL DISCUSSIONS REGARDING TARIFFS ON PHARMACEUTICALS
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN EDWARD GREISSING | — |
Taxation/Internal Revenue Code TAX
GENERAL DISCUSSIONS REGARDING ORPHAN DRUG TAX CREDIT
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN EDWARD GREISSING | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.